Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001193125-25-335956·Cloopen Group Holding Ltd
Schedule 13D ownership disclosure
Cloopen Group Holding Ltd
Class A Ordinary Shares, par value US$0.0001 per share · CUSIP: 18900M203
Event date: 2025-12-22
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- TB Alternative Assets Ltd.Reported CIK 0001483503
Shares: 38,474,611 · Class: 12.19%
- Trustbridge Partners V, L.P.
Shares: 38,474,611 · Class: 12.19%
- Trustbridge Partners VII, L.P.Reported CIK 0001833327
Shares: 38,474,611 · Class: 12.19%
- TB Partners GP5 Limited
Shares: 38,474,611 · Class: 12.19%
- TB Partners GP7 Limited
Shares: 38,474,611 · Class: 12.19%
- Changxun SunReported CIK 0001907822
Shares: 27,649,839 · Class: 8.76%
- Cloopen Co., Ltd.
Shares: 25,649,839 · Class: 8.13%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-25-335956
- Form type
- SCHEDULE 13D
- Filer
- Cloopen Group Holding Ltd
- CIK
- CIK 1804583
- Filed
- Dec 30, 2025
- Reporting period
- Dec 22, 2025
- Description
- Schedule 13D beneficial ownership